WASHINGTON — Today, Select Subcommittee on the Coronavirus Pandemic Chairman Brad Wenstrup (R-Ohio) announced that Dr. Anthony Fauci will appear before the 118th Congress for the first time for a two-day, transcribed interview on January 8, 2024 and January 9, 2024. Additionally, Dr. Fauci has agreed to testify in front of the Select Subcommittee at a public hearing later next year.
The full terms of his testimony are detailed below:
A transcribed interview to occur on January 8 and 9, 2024;
Seven hours of testimony, excluding breaks, per day;
Attendance by two personal and two government counsel; and
A public hearing at a date to be named later.
“Dr. Fauci was the face of America’s public health response during the COVID-19 pandemic, and his testimony will serve as a crucial component of the Select Subcommittee’s investigations into the origin of COVID-19, coercive mandates, gain-of-function type research, scientific censorship, and more.” said Chairman Wenstrup. “It is time for Dr. Fauci to confront the facts and address the numerous controversies that have arisen during and after the pandemic. Americans deserve trusted public health leaders who prioritize the well-being of our people over any personal or political goals. Thankfully, retirement from public service does not shield one from Congressional oversight nor accountability to the American people. During Dr. Fauci’s upcoming testimonies, honesty is non-negotiable.”
Previously, the Select Subcommittee revealed evidence that Dr. Fauci prompted the drafting of the now infamous “Proximal Origin” publication to disprove the lab leak theory. He then citied the paper from the White House podium without disclosing his involvement in prompting the publication. Further, the Select Subcommittee revealed that Dr. Fauci was aware of dangerous gain-of-function research occurring in Wuhan, China prior to the emergence of COVID-19, but remained curiously silent to the public.
Read Chairman Wenstrup’s letter to Dr. Anthony Fauci detailing the terms of his transcribed interview here.